{"contentid": 488499, "importid": NaN, "name": "Merck & Co comes up short in sales and earnings", "introduction": "US pharma major Merck & Co became the latest drugmaker to announce disappointing, pandemic-hit first quarter 2021 financial results, sending shares in the company down by 3% in Thursday\u00e2\u0080\u0099s early trading.", "content": "<p>US pharma major Merck &amp; Co (NYSE: MRK) became the latest drugmaker to announce disappointing, pandemic-hit first quarter 2021 financial results, sending shares in the company down by 3% in Thursday&rsquo;s early trading.</p>\n<p>Overall revenue at the group inched up to $12.08 billion from $12.06 billion, but was below the FactSet consensus of $12.61 billion, as pharmaceutical sales edged up 0.2% to $10.68 billion.</p>\n<p>Excluding non-recurring items, adjusted earnings per share (EPS) fell to $1.40 from $1.51, heavily missing the FactSet consensus of an increase to $1.61.</p>\n<p>Merck has not changed its 2021 guidance for revenue and adjusted EPS, the company said, in what was chief executive Ken Frazier&rsquo;s final financial results presentation ahead of his retirement on June 30, when he will be replaced by Robert Davis.</p>\n<p>Mr Frazier said: &ldquo;While our results this quarter were impacted by the pandemic, the underlying demand for our innovative products remains strong and we remain confident in our future growth prospects. We are also taking the right steps to evolve Merck&rsquo;s operating model to continue to create value for patients, shareholders and society.&rdquo;</p>\n<p>Mr Davis added: &ldquo;As I transition into the CEO role, one of my immediate priorities is to ensure that our experienced leadership team continues to build on our solid foundation,&rdquo; said Robert Davis, president, Merck. &ldquo;Our company is well positioned for strong long-term performance, with scientific innovation remaining the source of our company&rsquo;s energy and value creation.&rdquo;</p>\n<h2>Key product sales</h2>\n<p>Keytruda (pembrolizumab): $3.9 billion, up 19%</p>\n<p>Januvia/Janumet (sitagliptin/sitagliptin and metformin): $1.3 billion, up 1%</p>\n<p>Gardasil /Gardasil 9: $917 million, down 16%</p>\n<p>Proquad, M-M-R II and Varivax: $449 million, up 3%</p>\n<p>Bridion (sugammadex): $340 million, up 14%</p>", "date": "2021-04-29 14:40:00", "meta_title": NaN, "meta_keywords": "Merck, billion, results, company, sales, financial, quarter, earnings, short, disappointing, announce, drugmaker, latest, major, pharma, pandemic-hit, earl", "meta_description": "US pharma major Merck & Co became the latest drugmaker to announce disappointing, pandemic-hit first quarter financial results, sending shares in the company do", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-29 14:38:41", "updated": "2021-04-29 15:25:21", "access": NaN, "url": "https://www.thepharmaletter.com/article/merck-co-comes-up-short-in-sales-and-earnings", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "kenneth_frazier_merck_co_large.jpg", "image2id": "kenneth_frazier_merck_co_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Immuno-oncology, Oncology, Vaccines", "topic_tag": "Financial, Management", "geography_tag": "USA", "company_tag": "Merck & Co", "drug_tag": "Bridion, Gardasil, Januvia/Janumet, Keytruda, Proquad", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-29 14:40:00"}